GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stem Cells Spin SA (WAR:SCS) » Definitions » EBITDA Margin %

Stem Cells Spin (WAR:SCS) EBITDA Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stem Cells Spin EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Stem Cells Spin's EBITDA for the three months ended in Sep. 2024 was zł0.15 Mil. Stem Cells Spin's Revenue for the three months ended in Sep. 2024 was zł0.00 Mil. Therefore, Stem Cells Spin's EBITDA margin for the quarter that ended in Sep. 2024 was 0.00%.


Stem Cells Spin EBITDA Margin % Historical Data

The historical data trend for Stem Cells Spin's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Cells Spin EBITDA Margin % Chart

Stem Cells Spin Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.66 473.88 145.82 395.97 222.43

Stem Cells Spin Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.28 175.31 3,700.00 - -

Competitive Comparison of Stem Cells Spin's EBITDA Margin %

For the Biotechnology subindustry, Stem Cells Spin's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Cells Spin's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stem Cells Spin's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Stem Cells Spin's EBITDA Margin % falls into.



Stem Cells Spin EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Stem Cells Spin's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=0.932/0.419
=222.43 %

Stem Cells Spin's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0.153/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stem Cells Spin  (WAR:SCS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Stem Cells Spin EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Stem Cells Spin's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stem Cells Spin Business Description

Traded in Other Exchanges
N/A
Address
Ulica Konopnickiej 15 b, Wroclaw, POL, 51-141
Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1 and Velvetyna.